Concepedia

Megan E. Honeywell

ME

Statistics

Publications

8

Citations

235

H-Index

8

Active since

2018

Affiliations

University of Massachusetts Chan Medical School(Current)

Megan E. Honeywell is an author at University of Massachusetts Chan Medical School specializing in cancer biology, apoptosis, and medicine.

ORCID

Publications per year

2018–2025

8

Publications

8

Drug antagonism and single-agent dominance result from differences in death kinetics

Ryan Richards, Hannah Schwartz, Megan E. Honeywell et al. · Nature Chemical Biology · 2020 · 45 citations · Full text

, , +6

Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells

Benjamin Landry, Thomas Leete, Ryan Richards et al. · Molecular Systems Biology · 2018 · 43 citations · Full text

, , +17

Modeling of Cisplatin-Induced Signaling Dynamics in Triple-Negative Breast Cancer Cells Reveals Mediators of Sensitivity

Anne Margriet Heijink, Marieke Everts, Megan E. Honeywell et al. · Cell Reports · 2019 · 42 citations · Full text

, , +17

Drug GRADE: An Integrated Analysis of Population Growth and Cell Death Reveals Drug-Specific and Cancer Subtype-Specific Response Profiles

Hannah Schwartz, Ryan Richards, Rachel E. Fontana et al. · Cell Reports · 2020 · 27 citations · Full text

, , +14

ELP-dependent expression of <i>MCL1</i> promotes resistance to EGFR inhibition in triple-negative breast cancer cells

Peter Cruz‐Gordillo, Megan E. Honeywell, Nicholas W. Harper et al. · Science Signaling · 2020 · 25 citations · Full text

, , +17

1–5 of 8